Basilea Pharmaceutica AG carries a market capitalization of 957.95M, placing it among publicly traded companies globally.
| Market Cap | 957.95M |
| Enterprise Value | N/A |
Basilea Pharmaceutica AG's stock has gained approximately 14.24354% over the past 52 weeks. The 50-day moving average sits at 65.59, while the 200-day moving average is 66.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | 14.24354% |
| 50-Day Moving Average | 65.59 |
| 200-Day Moving Average | 66.86 |
| Average Volume (20 Days) | N/A |